The CGM grey market: a reflection of global access inequity

Studies have shown that patients with type 1 diabetes who use continuous glucose monitoring (CGM) technology have better glycaemic control than those without CGM, irrespective of their insulin delivery method. 1 Pickup JC Freeman SC Sutton AJ Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient...